Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Sedimentation and Other Properties of the Reconstituted Liver Microsomal Mixed-Function Oxidase System Containing Cytochrome P-450, Reduced Triphosphopyridine Nucleotide—Cytochrome P-450 Reductase, and Phosphatidylcholine

ANNE P. AUTOR, ROBERT M. KASCHNITZ, JOANNE K. HEIDEMA and MINOR J. COON
Molecular Pharmacology January 1973, 9 (1) 93-104;
ANNE P. AUTOR
Department of Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan 48104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT M. KASCHNITZ
Department of Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan 48104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOANNE K. HEIDEMA
Department of Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan 48104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MINOR J. COON
Department of Biological Chemistry, The University of Michigan Medical School, Ann Arbor, Michigan 48104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effect of phosphatidylcholine, an essential component of the reconstituted liver microsomal enzyme system which hydroxylates drugs, on the sedimentation and other properties of cholate-solubilized cytochrome P-450 was studied. Upon centrifugation of the cytochrome P-450 fraction for 1 hr at 105,000 x g at 5°, 85-90% of the cytochrome P-450 remained in the supernatant fraction. The apparent sedimentation coefficient of the cytochrome P-450 was 13 S, whether this fraction was centrifuged alone or in the presence of the reductase fraction and phosphatidylcholine. When the concentration of bound cholate was reduced by dialysis to approximately 1 µg/mg of protein, corresponding to about 1 mole/mole of cytochrome P-450, almost full catalytic activity was retained and an apparent sedimentation coefficient of 18 S was observed. This value was not altered by the addition of the reductase fraction and the lipid. The molecular weight of the dialyzed cytochrome P-450 was judged to be about 350,000 by sedimentation velocity measurements in the ultracentrifuge, sucrose density gradient centrifugation, and gel exclusion chromatography, but this figure must be considered provisional in view of the heterogeneity of the preparation. The effect of sedimentation on the distribution of enzyme activity was also determined. After centrifugation of the complete reaction mixture containing the cytochrome P-450 fraction, the reductase fraction, phosphatidylcholine, TPNH, and benzphetamine for 1 hr at 105,000 x g, over 90% of the original hydroxylation activity remained in the supernatant layer. The resuspended pellet was inactive when supplemented with TPNH and substrate. When the reconstituted enzyme system was subjected to gel exclusion chromatography, the cytochrome P-450 and TPNH—cytochrome P-450 reductase were well separated from each other and from the phospholipid, thereby indicating that these components behave as separate entities rather than as a tightly associated complex. The solubilized cytochrome P-450 fraction was examined in the electron microscope and found to have the appearance of individual protein molecules rather than of highly complex structures. Similarly, a mixture of the cytochrome P-450 fraction, the reductase fraction, and phospholipid was devoid of structures which could be attributed to aggregation. These findings indicate that, although a dissociable complex containing cytochrome P-450, reductase, and phosphatidylcholine may function in catalysis, the phospholipid exerts its effect on drug hydroxylation without causing the formation of aggregates or membrane-like structures.

ACKNOWLEDGMENTS The authors wish to thank Dr. J. L. Oncley and Mr. J. T. Trojanowski for collaborating in the sedimentation and diffusion measurements.

  • Copyright ©, 1973, by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 9, Issue 1
1 Jan 1973
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sedimentation and Other Properties of the Reconstituted Liver Microsomal Mixed-Function Oxidase System Containing Cytochrome P-450, Reduced Triphosphopyridine Nucleotide—Cytochrome P-450 Reductase, and Phosphatidylcholine
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Sedimentation and Other Properties of the Reconstituted Liver Microsomal Mixed-Function Oxidase System Containing Cytochrome P-450, Reduced Triphosphopyridine Nucleotide—Cytochrome P-450 Reductase, and Phosphatidylcholine

ANNE P. AUTOR, ROBERT M. KASCHNITZ, JOANNE K. HEIDEMA and MINOR J. COON
Molecular Pharmacology January 1, 1973, 9 (1) 93-104;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Sedimentation and Other Properties of the Reconstituted Liver Microsomal Mixed-Function Oxidase System Containing Cytochrome P-450, Reduced Triphosphopyridine Nucleotide—Cytochrome P-450 Reductase, and Phosphatidylcholine

ANNE P. AUTOR, ROBERT M. KASCHNITZ, JOANNE K. HEIDEMA and MINOR J. COON
Molecular Pharmacology January 1, 1973, 9 (1) 93-104;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • EIPA, HMA and SMN2 gene regulation
  • Clc-2 has minor role in intestinal Cl- secretion
  • Resveratrol acts as an NR4A1 antagonist in lung cancer.
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics